First Chief Financial Officer at Genentech, 1978-1984: Oral History Transcript / 200 (Paperback) (ISBN-13: 9781176637689)

This oral history transcript documents the experiences of the first Chief Financial Officer at Genentech from 1978 to 1984. It provides insights into the early financial strategies and challenges faced by one of the pioneering companies in the biotechnology industry. The interview captures the perspectives of Fred A. Middleton, offering a unique inside view of Genentech's formative years.

Researchers and those interested in the history of biotechnology, corporate finance, and management will find this transcript invaluable. It sheds light on the innovative approaches and critical decisions that shaped Genentech's early success, making it essential reading for anyone studying the development of the biotech sector. The transcript preserves firsthand accounts of key events and provides rich context for understanding Genentech's rise.

This work has been selected by scholars as being culturally important, and is part of the knowledge base of civilization as we know it. This work was reproduced from the original artifact, and remains as true to the original work as possible. Therefore, you will see the original copyright references, library stamps (as most of these works have been housed in our most important libraries around the world), and other notations in the work.

This work is in the public domain in the United States of America, and possibly other nations. Within the United States, you may freely copy and distribute this work, as no entity (individual or corporate) has a copyright on the body of the work.

As a reproduction of a historical artifact, this work may contain missing or blurred pages, poor pictures, errant marks, etc. Scholars believe, and we concur, that this work is important enough to be preserved, reproduced, and made generally available to the public. We appreciate your support of the preservation process, and thank you for being an important part of keeping this knowledge alive and relevant.